All SEC Filings :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

All SEC Filings

Filing Type:

Year:

Date	Form	Description	PDF	XBRL	Pages
02/21/13	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities			6
02/21/13	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities			7
02/21/13	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities			6
02/13/13	8-K/A	Current report filing Documents EX-3.2 EX-10.3 EX-14.1 EX-16.1			37
02/12/13	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
02/12/13	8-K	Current report filing Documents EX-3.2 EX-10.3 EX-14.1 EX-16.1			37
11/30/12	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities			10
11/30/12	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities			14
11/30/12	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities			10
11/30/12	8-K	Current report filing Documents EX-10.1 EX-10.2			27

31
32
33
34
35
36
37
38
39
40